Insider: Mulligan Seamus Director - Jazz Pharmaceuticals plc
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 1,123,031 | 101,621 | 1,224,652 |
| Value | $143,523,361.80 | $12,987,163.80 | $156,510,525.60 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/12/2025 | AAP | 1,621 | Indirect | COM | $103.00 | $166,961.54 | 101,621 |
| 05/09/2025 | AAP | 19,216 | Indirect | COM | $98.91 | $1,900,677.62 | 99,900 |
| 05/09/2025 | AAP | 80,684 | Indirect | COM | $98.10 | $7,915,471.55 | 80,684 |
| 05/09/2025 | AAP | 100 | Indirect | COM | $99.71 | $9,971.00 | 100,000 |
| 05/27/2020 | AAP | 5,243 | Direct | COM | $109.55 | $574,379.04 | 1,123,031 |
| 05/27/2020 | AAP | 8,391 | Direct | COM | $110.52 | $927,351.50 | 1,131,422 |
| 05/27/2020 | AAP | 9,884 | Direct | COM | $111.56 | $1,102,681.77 | 1,141,306 |
| 05/27/2020 | AAP | 11,482 | Direct | COM | $112.32 | $1,289,645.61 | 1,152,788 |
| 05/26/2020 | AAP | 15,000 | Direct | COM | $110.65 | $1,659,747.00 | 1,117,788 |
| 11/15/2018 | AAP | 22,137 | Direct | COM | $145.05 | $3,210,892.16 | 1,100,868 |
| 11/15/2018 | AAP | 300 | Direct | COM | $141.86 | $42,558.99 | 1,051,168 |
| 11/15/2018 | AAP | 1,200 | Direct | COM | $143.22 | $171,869.04 | 1,052,368 |
| 11/15/2018 | AAP | 26,363 | Direct | COM | $144.24 | $3,802,680.85 | 1,078,731 |
| 08/25/2016 | DDS | 3,565 | Direct | COM | $126.65 | $451,510.82 | 1,072,411 |
| 08/25/2016 | DDS | 9,500 | Direct | COM | $127.70 | $1,213,176.60 | 1,062,911 |
| 08/25/2016 | DDS | 4,620 | Direct | COM | $129.42 | $597,908.39 | 1,048,008 |
| 08/25/2016 | DDS | 10,283 | Direct | COM | $128.97 | $1,326,191.31 | 1,052,628 |
| 05/24/2016 | DDS | 1,400 | Direct | COM | $148.65 | $208,104.96 | 1,101,179 |
| 05/24/2016 | DDS | 11,888 | Direct | COM | $149.64 | $1,778,892.98 | 1,089,291 |
| 05/24/2016 | DDS | 4,726 | Direct | COM | $151.51 | $716,036.26 | 1,074,611 |
| 05/24/2016 | DDS | 9,954 | Direct | COM | $150.72 | $1,500,304.71 | 1,079,337 |
| 02/23/2016 | DDS | 2,716 | Direct | COM | $120.68 | $327,761.45 | 1,127,831 |
| 02/23/2016 | DDS | 4,779 | Direct | COM | $122.03 | $583,174.20 | 1,123,052 |
| 02/23/2016 | DDS | 15,824 | Direct | COM | $122.83 | $1,943,704.64 | 1,107,228 |
| 02/23/2016 | DDS | 1,722 | Direct | COM | $124.78 | $214,867.03 | 1,102,579 |
| 1 2 3 4 Next Last You are at page 1 of 4 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research